Thomas Bodmer
Overview
Explore the profile of Thomas Bodmer including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
56
Citations
989
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Roditscheff A, Egli K, Vianin A, Lortscher F, Reidla J, Wehrli F, et al.
Eur J Clin Microbiol Infect Dis
. 2025 Feb;
PMID: 39930296
Purpose: Molecular methods to detect antimicrobial resistance in Neisseria gonorrhoeae (Ng) are increasingly needed worldwide to improve diagnostic tests and enable individualized patient treatments. The Allplex™ NG & DR Assay...
2.
Hilti D, Wehrli F, Berchtold S, Bigler S, Bodmer T, Seth-Smith H, et al.
Microorganisms
. 2024 Feb;
12(2).
PMID: 38399725
During the SARS-CoV-2 pandemic, the Dr. Risch medical group employed the multiplex TaqPath COVID-19 CE-IVD RT-PCR Kit for large-scale routine diagnostic testing in Switzerland and the principality of Liechtenstein. The...
3.
Benvenga V, Cuenod A, Purushothaman S, Dasen G, Weisser M, Bassetti S, et al.
Genome Med
. 2024 Feb;
16(1):23.
PMID: 38317199
Background: Few methicillin-resistant Staphylococcus aureus (MRSA) from the early years of its global emergence have been sequenced. Knowledge about evolutionary factors promoting the success of specific MRSA multi-locus sequence types...
4.
Hilti D, Wehrli F, Roditscheff A, Risch M, Risch L, Egli A, et al.
Pathogens
. 2023 Dec;
12(12).
PMID: 38133268
At the end of 2021, we observed an increase in N-gene target failures (NGTF) with the TaqPathTM COVID-19 CE-IVD RT-PCR Kit from Thermo Fisher Scientific (TaqPath). We subsequently used whole-genome...
5.
Campos-Madueno E, Moser A, Jost G, Maffioli C, Bodmer T, Perreten V, et al.
J Glob Antimicrob Resist
. 2022 Dec;
31:394.
PMID: 36526358
No abstract available.
6.
Egli K, Risch M, Risch L, Bodmer T
BMC Microbiol
. 2022 May;
22(1):119.
PMID: 35501697
Background: 16S rDNA-PCR for the identification of a bacterial species is an established method. However, the DNA extraction reagents as well as the PCR reagents may contain residual bacterial DNA,...
7.
Campos-Madueno E, Moser A, Jost G, Maffioli C, Bodmer T, Perreten V, et al.
J Glob Antimicrob Resist
. 2022 Jan;
28:206-215.
PMID: 35085791
Background: The spread of carbapenemase-producing Klebsiella pneumoniae (CP-Kp) strains belonging to high-risk sequence types (STs) is a concern. For Switzerland, national data about the molecular features (especially the STs) of...
8.
Chen C, Nadeau S, Topolsky I, Manceau M, Huisman J, Jablonski K, et al.
Epidemics
. 2021 Sep;
37:100480.
PMID: 34488035
Background: In December 2020, the United Kingdom (UK) reported a SARS-CoV-2 Variant of Concern (VoC) which is now named B.1.1.7. Based on initial data from the UK and later data...
9.
Egli K, Roditscheff A, Fluckiger U, Risch M, Risch L, Bodmer T
Ann Clin Microbiol Antimicrob
. 2021 Aug;
20(1):52.
PMID: 34362393
Background: The resistance of Neisseria gonorrhoeae to ceftriaxone is unusual in Switzerland. The underlying genotype responsible for resistance is suspected to be novel. Generally, resistance in Neisseria gonorrhoeae (Ng) involves...
10.
Campos-Madueno E, Moser A, Risch M, Bodmer T, Endimiani A
Antimicrob Agents Chemother
. 2021 Jun;
65(9):e0072421.
PMID: 34181480
The spread of plasmid-mediated carbapenemases within Klebsiella oxytoca is well-documented. In contrast, data concerning the closely related species Klebsiella grimontii are scarce. In fact, despite the recent report of the...